Christopher Martell
Director, Candel Therapeutics.
Companies
- Candel TherapeuticsBoard member Jul 26, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Candel Therapeutics CADL435,514 shares2$3.5M at $8.14Jun 26, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 25, 2025Granted 111,349 shares at $4.67 of Candel Therapeutics2
- Dec 9, 2022Bought 23,950 shares at $1.92 of Candel Therapeutics3
- Dec 9, 2022Bought 23,950 shares at $1.92 of Candel Therapeutics4
- Dec 8, 2022Bought 3,050 shares at $1.68 of Candel Therapeutics3
- Dec 8, 2022Bought 3,050 shares at $1.68 of Candel Therapeutics4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCandel Therapeutics, Board member
- 2
- 3SEC EDGARForm 4 filed Dec 12, 2022
- 4SEC EDGARForm 4 filed Feb 17, 2023